Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome

• Published in: Cancers 2019-08, Vol.11 (9), p.1219
• Main Authors: Gatta, Luisa Benerini, Melocchi, Laura, Bugatti, Mattia, Missale, Francesco, Lonardi, Silvia, Zanetti, Benedetta, Cristinelli, Luca, Belotti, Sandra, Simeone, Claudio, Ronca, Roberto, Grillo, Elisabetta, Licini, Sara, Bresciani, Debora, Tardanico, Regina, Chan, Szeman Ruby, Giurisato, Emanuele, Calza, Stefano, Vermi, William
• Format: Article
• Language: English
• Subjects: Animal models; Biomarkers; Bladder cancer; Cell viability; Gene expression; Genomes; Immunohistochemistry; Kinases; Localization; Medical prognosis; Morphology; Mutation; Myc protein; Phosphorylation; Signal transduction; Stat3 protein; Transcription factors; Tumor cell lines; Urothelial cancer
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers11091219

Urothelial bladder cancer (UBC) are classified into luminal and basal subtypes showing distinct molecular features and clinical behaviour. Recent in silico data have proposed the activation on the Signal Transducer and Activator of Transcription 3 (STAT3) as relevant transcription factor in UBC. To answer this question, we have combined the retrospective analysis of clinical samples, functional assays on cell lines, interrogation of public UBC datasets and a murine model of basal-type UBC. Immunohistochemistry on a retrospective UBC cohort uncovered that STAT3 Y705 phosphorylation (pSTAT3) is significantly increased in infiltrating basal-type UBC compared to luminal UBC. In vitro, STAT3 silencing in UBC cell lines significantly reduced tumor cell viability and invasion. Gene expression profile of UBC cell lines combined with the analysis of the Cancer Genome Atlas (TCGA) and GSE32894 UBC datasets showed that increased expression of a set of STAT3 targets predicts basal-type, propensity to local progression and worse prognosis. MYC and FOSL1 represent relevant STAT3 downstream targets, as validated by their co-localization in pSTAT3+ UBC cancer cells. These findings were largely reproduced in the BBN-induced murine model of basal-type UBC. Of note, FOSL1 protein resulted strongly expressed in the non-papillary UBC pathway and FOSL1-regulated transcripts were significantly enriched in the transition from NMIBC to MIBC, as indicated by the interrogation of the GSE32894 dataset. The blockade of the STAT3 pathway might represent a novel treatment option for these neoplasms. Monitoring pSTAT3 and the downstream targets, particularly FOSL1, could provide meaningful levels of UBC stratification.